Bayer to Present Investigational Data from Comprehensive KERENDIA® (finerenone) Clinical Trial Program at Heart Failure 2024 Congress
Late-breaking data from a new pre-specified pooled analysis, FINE-HEART, to investigate the effects of finerenone on cardio-kidney outcomes among specific patient... Read more.
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akero Therapeutics, Inc. (AKRO)
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming June 25, 2024 deadline to file a lead plaintiff... Read more.
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akero Therapeutics, Inc. (AKRO)
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming June 25, 2024 deadline to file a lead plaintiff... Read more.
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Anavex Life Sciences Corp. (AVXL)
LOS ANGELES–(BUSINESS WIRE)–The Law Offices of Frank R. Cruz reminds investors of the upcoming May 13, 2024 deadline to file a lead plaintiff motion... Read more.
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Exscientia p.l.c. (EXAI)
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming June 25, 2024 deadline to file a lead plaintiff... Read more.
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Exscientia p.l.c. (EXAI)
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming June 25, 2024 deadline to file a lead plaintiff... Read more.
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AXT, Inc. (AXTI)
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming July 5, 2024 deadline to file a lead plaintiff... Read more.
World PEGylated Proteins Analysis Report 2023-2028: Increasing Utilization of Protein Drugs in Hematology and Oncology Bodes Well for the Market – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “PEGylated Proteins Market 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The global... Read more.
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Next Bridge Hydrocarbons, Inc.
LOS ANGELES–(BUSINESS WIRE)–The Law Offices of Frank R. Cruz reminds investors of the upcoming May 14, 2024 deadline to file a lead plaintiff motion... Read more.
Shokz Announces Partnership with Olympic Gold Medalist and Three-Time IRONMAN World Champion, Jan Frodeno
Be Open with Shokz: Triathlete Legend Jan Frodeno Showcases OpenRun Pro, OpenSwim Pro and OpenFit AUSTIN, Texas–(BUSINESS WIRE)–Shokz, known for its... Read more.